• Thus, cell A now completely trusts B.

    因此,计算单元a现在完全信任计算单元b。

    youdao

  • Server B thus has administrative authority over server a's cell.

    服务器b因而具有对服务器a的计算单元的管理权限。

    youdao

  • Obviously servers in cell B trust cell A as they accept identity assertion from it.

    显然,计算单元B中服务器从计算单元 A 中接受标识断言,因此是信任计算单元 A 的。

    youdao

  • For servers in cell B to accept the identity assertion, the upstream server in cell a must authenticate itself first.

    对于计算单元b中接受标识断言的服务器,计算单元a中的上游服务器必须首先对自身进行身份验证。

    youdao

  • A two - (or more) cell strategy provides the capability to divert traffic to an alternate cell (cell b) while maintenance is being applied to a primary cell (cell a).

    在您对主要单元(单元a)进行维护时,一个两单元(或者多单元)策略可以使流量转移到一个可替换的单元(单元b)。

    youdao

  • Background: MZL are uncommon B-cell lymphomas.

    背景:边缘区淋巴瘤是比较少见的B细胞淋巴瘤。

    youdao

  • B-cell lymphoma was the predominant type, seen in 42 of 45 cases (93.3%).

    其中B细胞性淋巴瘤是最常见的病理类型,占93.3%(42/45)。

    youdao

  • Conclusion Most cases were B-cell type lymphoma with low-grade malignancy.

    结论11例胃malt淋巴瘤中大多数示低度恶性B细胞性淋巴瘤。

    youdao

  • The biological immune system employs B-Cell and T-Cell in detecting antigen.

    在机体免疫系统中,B淋巴细胞和T淋巴细胞协同起来识别抗原。

    youdao

  • It is always the non-Hodgkin type, and the vast majority are B-cell lymphomas.

    几乎全部都是非霍奇金淋巴瘤,而且绝大部分为B细胞淋巴瘤。

    youdao

  • Results All the 11cases were B-cell type lymphoma, and male patients were more common.

    结果11例胃MALT淋巴瘤全部示B细胞性淋巴瘤,且男性多于女性。

    youdao

  • Selection and identification of B-cell epitopes are important for tumor vaccine designing.

    因此,筛选并鉴定肿瘤B细胞表位对肿瘤疫苗设计具有重要意义。

    youdao

  • The B-cell receptor also represents an important target for patients with B-cell malignancies.

    对于B细胞淋巴瘤患者,B细胞受体也代表着一个很重要的药物标靶。

    youdao

  • Background: MZL are uncommon B-cell lymphomas. The outcomes and prognostic factors of MZL remain poorly defined.

    背景:边缘区淋巴瘤是比较少见的B细胞淋巴瘤。边缘区淋巴瘤的转归和预后因子尚不明确。

    youdao

  • The present invention generally provides methods for B-cell reduction in an individual using CD37-specific binding molecules.

    本申请总体来说提供了用CD37 -特异性结合分子在个体中减少B -细胞的方法。

    youdao

  • CD200 staining by flow cytometry can be useful in the differential diagnosis of B-cell neoplasms and in their detection in the BM.

    通过流式细胞仪检测,CD 200染色可用于B细胞肿瘤的鉴别诊断和BM检查。

    youdao

  • Multiple novel targeted agents are emerging for B-cell malignancies, but few studies have successfully and safely combined these agents.

    现在出现了多种治疗B细胞恶性肿瘤的新型靶向药物,但是很少有研究成功并安全地联合这些药物。

    youdao

  • Differential Expression of CD200 in B-Cell Neoplasms by Flow Cytometry Can Assist in Diagnosis, Subclassification, and Bone Marrow Staging.

    通过流式细胞仪检测CD 200在B细胞肿瘤中的差异性表达可以协助诊断、分类与骨髓分期。

    youdao

  • Objective To discuss further scientific, brief and applied Math Judgment Method about the Function of Pancreas B-cell and Insulin Resistance.

    目的进一步探讨胰岛B细胞功能及胰岛素抵抗科学、简便、实用的数学判定法。

    youdao

  • Insulin resistance and B-cell dysfunction are the two main components in the pathogenesis of type 2 diabetes, and insulin resistance is initial factor.

    胰岛素抵抗和B细胞功能障碍是2型糖尿病发病机制的两个主要环节,而胰岛素抵抗是2型糖尿病发生的始动因素。

    youdao

  • Moreover, 61 (90%) of 68 of NK cell neoplasms demonstrated CD335 expression, whereas B-cell, myelomonocytic, and plasma cell neoplasms lacked expression.

    此外,在68例nk细胞肿瘤中有61例(90%)表达CD335,而B细胞肿瘤、骨髓单核细胞肿瘤、浆细胞瘤则缺乏表达。

    youdao

  • Objective to observe the effect and toxicity of rituximab and CHOP regimen (R-CHOP) in the treatment of initially diagnosed diffuse large B-cell lymphoma.

    目的观察利妥昔单抗联合CHOP方案(R - CHOP)治疗初治弥漫大B细胞型淋巴瘤的疗效以及毒副反应。

    youdao

  • To analyze CD200 expression by flow cytometry in a large series of B-cell neoplasms in a variety of tissue types in comparison with benign B-lineage cells.

    通过流式细胞仪检测,分析在一系列各种组织类型的B细胞肿瘤中CD200表达情况,并与良性B系细胞进行比较。

    youdao

  • Objective: To investigate the BCL-6 gene alterations in B-cell Non-Hodgkin's lymphomas (B-NHL) in Chinese populations and its clinic-pathological significance.

    目的:系统性地研究中国人B - NHL常见类型中bcl - 6基因的异常,并探讨其临床病理意义。

    youdao

  • While, monoclonal antibody against CD20 antigen on the membrane of B-cell NHLs and normal B-lymphocyte showed satisfactory curative effect in clinical treatment of NHL.

    针对B淋巴瘤细胞和B淋巴细胞表面CD 20抗原的单克隆抗体治疗NHL取得了较好的效果。

    youdao

  • Objectives To evaluate the efficacy and toxicity of the B-NHL-BFM-90 protocol in the treatment of Chinese childhood and adolescent B-cell non-Hodgkin's lymphomas(B-NHL).

    目的评价德国NHL-BFM-90方案治疗中国儿童青少年B细胞非霍奇金淋巴瘤(B-NHL)的疗效和毒性。

    youdao

  • BRISH light chain restriction (LCR) results were concordant with FCM in 108 (99%) of 109 evaluable cases. Additional small B-cell lymphoma cohorts were successfully evaluated.

    在109例可评价的病例中,有108例(99%)BRISH检测轻链限制性(LCR)的结果与流式细胞仪一致,并成功评估了另外的小B细胞淋巴瘤病例组。

    youdao

  • PURPOSE: the current standard therapy for patients with diffuse large B-cell lymphoma (DLBCL) is rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP).

    背景:目前,弥漫大b细胞性淋巴瘤(DLBCL)的标准治疗方案为利妥昔单抗联合CHOP方案化疗(R - CHOP)。

    youdao

  • Receptor tyrosine kinase-like orphan receptor-1 (ROR1) is expressed on sub-populations of B-cell malignancies and solid tumors, but not by healthy B cells or normal postpartum tissues.

    受体酪氨酸激酶样孤儿受体1(ROR1)是在B-细胞恶性肿瘤和实体瘤亚群上表达的,但不在健康B细胞或正常产后组织中表达。

    youdao

  • Receptor tyrosine kinase-like orphan receptor-1 (ROR1) is expressed on sub-populations of B-cell malignancies and solid tumors, but not by healthy B cells or normal postpartum tissues.

    受体酪氨酸激酶样孤儿受体1(ROR1)是在B-细胞恶性肿瘤和实体瘤亚群上表达的,但不在健康B细胞或正常产后组织中表达。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定